GESSEL advised CenterMed on the acquisition of the Avimed Group
15.01.2026 Case studies Mergers and acquisitions (M&A) Typical scope of services provided in an M&A transaction on the buy side Life Sciences and Health Care Tax law
GESSEL advised CenterMed, a Polish network of outpatient clinics and medical facilities operating in the healthcare services market, on the acquisition of the AVIMED Group, a healthcare provider active in the Silesian region. The transaction involved the acquisition of an organised medical ecosystem comprising five medical facilities, a specialist hospital in Katowice, a rehabilitation centre, and specialised diagnostic and treatment units.
This acquisition furthers CenterMed’s strategy to consolidate the market for healthcare providers in Poland and to expand its integrated offering covering primary healthcare, specialist outpatient care, diagnostics, rehabilitation, and hospital treatment. The combination of the two groups strengthens CenterMed’s regional market position and enhances access to highly specialised medical services in Silesia.
“Transactions in the healthcare sector require a combination of regulatory expertise, transactional know-how, and a thorough understanding of the operational specifics of medical businesses. We are pleased to have supported CenterMed in another strategic acquisition and to have successfully guided this project from the initial analysis through to completion,” said Marcin Macieszczak, Managing Partner at GESSEL.
Lawyers involved in the project
Marcin Macieszczak
Managing Partner
Attorney-at-law
Mergers and acquisitions (M&A) | Private Equity
Monika Żulińska
Managing Associate
Attorney-at-law
Corporate law | Mergers and acquisitions (M&A) | Competition and consumer law
Erazm Dutkiewicz
Senior Associate
Attorney-at-law
Corporate law | Life Sciences and Health Care
Dominika Ramírez-Wołkiewicz
Partner
Attorney-at-law
Tax advisor
Tax law | Private Clients
You may also like
05.08.2026
GESSEL advised Pure Biologics on a multi-stage transaction comprising a share exchange offer, debt-to-equity conversion and public share offering
GESSEL advised Pure Biologics S.A., a biopharmaceutical company listed on the Warsaw Stock Exchange, on a complex, multi-stage and multi-jurisdictional transaction combi...
29.07.2026
GESSEL advised the founders of Clicktrans on the sale of a majority stake to Spire Capital
GESSEL advised Agnieszka Korzeniewska and Michał Brzeziński, the founders of Clicktrans sp. z o.o., one of Europe's largest online marketplaces connecting customers with...